Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations     ATC     Antiinfectives for Systemic Use     Vaccines     Animal Vaccines    

Global Recombinant vaccines Market Research Report

Recombinant vaccines and Live attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Conjugate vaccines, DNA vaccines, Sub-unit vaccines and Other Vaccine technology adds up to total Animal Vaccines market.

Recombinant vaccines can be segmented by Types, Geographies, MacroIndicators and Companies. Types of this market are Preventive and Therapeutic. Geographies of this market are North America, Europe, Asia, Rest of World and Other Geographies. MacroIndicators of this market are Healthcare Expenditure. Companies of this market are Pfizer Inc, Sanofi, Merck & Co., Inc., Virbac, Bayer Pharmaceuticals and Other Companies.

 

Key Questions Answered

  • What are market estimates and forecasts; which of Recombinant vaccines markets are doing well and which are not?
  • What is the competitive landscape; How companies like Pfizer Inc, Sanofi and Merck & Co., Inc. doing in Recombinant vaccines?
  •  

    What makes our report unique?

    • This report provides market sizing and forecast for the Recombinant vaccines market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
    • The report provides deep dive competitive landscape covering the top players such as Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
    • The reports provides benchmarking insight on the top players Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
    • The report provide competitive intelligence on Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
    •  

      Audience for this report

      • Global Recombinant vaccines companies
      • Manufacturing Companies
      • Traders, distributors, and suppliers
      • Governmental and research organizations
      • Associations and industry bodies
      • Technology providers
show more
PRODUCT TITLE PUBLISHED
North American Recombinant vaccines Market North American Recombinant vaccines Market
The North American Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $118.1 million in 2013 and expected to be $151.5 million by 2018 at a CAGR of 5.1%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
European Recombinant vaccines Market European Recombinant vaccines Market
The European Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $140.2 million in 2013 and expected to be $190 million by 2018 at a CAGR of 6.3%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
2 of 2 items
2 reports | Show
Connect With Us
US/CAN : +1-888-502-0539